4-(4-methoxyphenyl)-2,3-dihydro-1H-1,5-benzodiazepine, 95.0%, 2g

2-Chloro-5-(methylsulfanyl)benzamide, 95%, 500mg

ethyl 4-(5-methylfuran-2-yl)-2,4-dioxobutanoate, 95.0%, 100mg

2,3,4,9-tetrahydro-1H-carbazole-3-carboxylic acid, 95.0%, 2g

1-(2-bromophenyl)-3-hydroxybut-2-en-1-one, 95%, 5g

Flat flange reaction vessel, cylindrical, graduated, with tempering and vacuum jacket and drain valve, DN 60, 1000 ml, 160 mm, 1 Piece

2-(4-Chloro-phenylamino)-5-methyl-thiazole-4-carboxylic acid ethyl ester, 95.0%, 1g

1-(4-(Trifluoromethoxy)phenyl)-2-thiourea, 98.0%, 1g

(S)-1-(2,4-Dimethylphenyl)ethanamine, 95%, 1g

(4-Nitrophenyl)(pyrrolidin-1-yl)methanone, 95.0%, 5g

1-(2-Chloro-5-fluoropyridin-3-yl)ethanone, 95.0%, 1g

L-Theanine>98.0%(T)1g

2-Fluoroacrylic acid, 98%, 10g